Comparison between Hamps Bio IPO and Yash Highvoltage IPO.
Hamps Bio IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Yash Highvoltage IPO is a SME Bookbuilding proposed to list at BSE SME.
Hamps Bio IPO | Yash Highvoltage IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price | Bookbuilding |
Listing At | BSE SME | BSE SME |
Lead Managers | Marwadi Chandarana Intermediaries Brokers Pvt.Ltd. | Indorient Financial Services Ltd. |
Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
Market Maker | Pure Broking Pvt.Ltd. | Alacrity Securities Ltd. |
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | RHP ![]() |
Anchor Investor | Anchor Investor ![]() | |
IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of Hamps Bio IPO is up to ₹5.91 Cr whereas the issue size of the Yash Highvoltage IPO is up to ₹104.51 Cr. The final issue price of Hamps Bio IPO is ₹51.00 per share and of Yash Highvoltage IPO is ₹146.00 per share.
Hamps Bio IPO | Yash Highvoltage IPO | |
---|---|---|
Face Value | ₹10 per share | ₹5 per share |
Issue Price (Lower) | ₹138.00 per share | |
Issue Price (Upper) | ₹146.00 per share | |
Issue Price (Final) | ₹51.00 per share | ₹146.00 per share |
Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
Discount (Employee) | ||
Market Lot Size | 2000 shares | 1000 shares |
Fresh Issue Size | 11,58,000 shares | 60,28,000 shares |
Fresh Issue Size (Amount) | up to ₹5.91 Cr | up to ₹88.01 Cr |
OFS Issue Size | 0 shares | 11,30,000 shares |
OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹16.50 Cr |
Issue Size Total | 11,58,000 shares | 71,58,000 shares |
Issue Size Total (Amount) | up to ₹5.91 Cr | up to ₹104.51 Cr |
Hamps Bio IPO opens on Dec 13, 2024, while Yash Highvoltage IPO opens on Dec 12, 2024. The closing date of Hamps Bio IPO and Yash Highvoltage IPO is Dec 17, 2024, and Dec 16, 2024, respectively.
Hamps Bio IPO | Yash Highvoltage IPO | |
---|---|---|
Anchor Bid Date | Dec 11, 2024 | |
Issue Open | Dec 13, 2024 | Dec 12, 2024 |
Issue Close | Dec 17, 2024 | Dec 16, 2024 |
Basis Of Allotment (Tentative) | Dec 18, 2024 | Dec 17, 2024 |
Initiation of Refunds (Tentative) | Dec 19, 2024 | Dec 18, 2024 |
Credit of Share (Tentative) | Dec 19, 2024 | Dec 18, 2024 |
Listing date (Tentative) | Dec 20, 2024 | Dec 19, 2024 |
Anchor Lockin End date 1 | Jan 16, 2025 | |
Anchor Lockin End date 2 | Mar 17, 2025 |
Hamps Bio IPO P/E ratio is 31.94, as compared to Yash Highvoltage IPO P/E ratio of 26.8.
Hamps Bio IPO | Yash Highvoltage IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | Hamps Bio Limited Financial Information (Restated)Hamps Bio Limited's revenue increased by 16.41% and profit after tax (PAT) rose by 39.47% between the financial year ending with March 31, 2024 and March 31, 2023.
| Yash Highvoltage Limited Financial Information (Restated)Yash Highvoltage Limited's revenue increased by 20.43% and profit after tax (PAT) rose by 5.61% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100.00 | 79.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 71.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 31.94 | 26.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹22.22 Cr. | ₹416.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 21.14% | 32.51% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 18.31% | 44.07% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.31 | 0.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹1.60 | ₹5.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 14.84% | 32.51% |
In the Hamps Bio IPO Retail Individual Investors (RII) are offered 5,80,000 shares while in Yash Highvoltage IPO retail investors are offered 5,80,000 shares. Qualified Institutional Buyers (QIB) are offered in Hamps Bio IPO and 14,32,000 shares in Yash Highvoltage IPO.
Hamps Bio IPO | Yash Highvoltage IPO | |
---|---|---|
Anchor Investor Reserveration | 21,46,000 shares | |
Market Maker Reserveration | 62,000 shares | 3,77,000 shares |
QIB | 14,32,000 shares | |
NII | 5,78,000 shares | 10,74,000 shares |
RII | 5,80,000 shares | 25,06,000 shares |
Employee | ||
Others | ||
Total | 11,58,000 shares | 71,58,000 shares |
Hamps Bio IPO subscribed 1,057.00x in total, whereas Yash Highvoltage IPO subscribed 181.82x.
Hamps Bio IPO | Yash Highvoltage IPO | |
---|---|---|
QIB (times) | 123.70x | |
NII (times) | 758.27x | 330.03x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1,342.04x | 151.52x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1,057.00x | 181.82x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O